We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.07B
AUM Growth
+$226M
Cap. Flow
-$6.05M
Cap. Flow %
-0.2%
Top 10 Hldgs %
24.71%
Holding
329
New
29
Increased
101
Reduced
173
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 25.97%
2 Technology 23.54%
3 Industrials 17.51%
4 Consumer Discretionary 11.34%
5 Communication Services 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URGN icon
101
UroGen Pharma
URGN
$2.26B
$5.59M 0.18%
286,805
+184,752
+181% +$3.92M
PZZA icon
102
Papa John's
PZZA
$778M
$5.52M 0.18%
62,306
-1,185
-2% -$112K
OMCL icon
103
Omnicell
OMCL
$1.7B
$5.5M 0.18%
42,350
-605
-1% -$77.6K
LSCC icon
104
Lattice Semiconductor
LSCC
$18.5B
$5.5M 0.18%
122,104
-1,647
-1% -$73.1K
BMRN icon
105
BioMarin Pharmaceuticals
BMRN
$12.7B
$5.47M 0.18%
72,505
-3,243
-4% -$265K
ENSG icon
106
The Ensign Group
ENSG
$10.7B
$5.27M 0.17%
56,160
-16,251
-22% -$1.39M
GFF icon
107
Griffon
GFF
$4.74B
$5.24M 0.17%
192,714
-2,203
-1% -$54.4K
WW
108
DELISTED
WW International
WW
$5.18M 0.17%
165,746
-2,913
-2% -$83.9K
ASND icon
109
Ascendis Pharma A/S
ASND
$16.7B
$5.18M 0.17%
40,173
-1,810
-4% -$275K
VICR icon
110
Vicor
VICR
$9.91B
$5.11M 0.17%
60,129
-524
-0.9% -$49.3K
ICFI icon
111
ICF International
ICFI
$1.67B
$5.09M 0.17%
58,292
-815
-1% -$68.1K
EHC icon
112
Encompass Health
EHC
$12.5B
$5.01M 0.16%
76,855
-1,054
-1% -$68.7K
TTEK icon
113
Tetra Tech
TTEK
$9.07B
$4.91M 0.16%
180,945
-2,640
-1% -$70K
NUVA
114
DELISTED
NuVasive, Inc.
NUVA
$4.9M 0.16%
74,759
-1,001
-1% -$60K
OR icon
115
OR Royalties Inc
OR
$6.25B
$4.89M 0.16%
443,835
-9,804
-2% -$112K
HRMY icon
116
Harmony Biosciences
HRMY
$2.28B
$4.85M 0.16%
146,905
+112,630
+329% +$3.95M
INMD icon
117
InMode
INMD
$875M
$4.72M 0.15%
130,454
-161,316
-55% -$5.23M
VMD icon
118
Viemed Healthcare
VMD
$359M
$4.55M 0.15%
+449,834
New +$4.23M
CVET
119
DELISTED
Covetrus, Inc. Common Stock
CVET
$4.53M 0.15%
151,050
-2,138
-1% -$72.9K
TRAK icon
120
ReposiTrak
TRAK
$156M
$4.49M 0.15%
734,926
+313,763
+74% +$1.95M
CALY
121
Callaway Golf Company
CALY
$3.08B
$4.45M 0.15%
166,360
-23,803
-13% -$673K
LNN icon
122
Lindsay Corp
LNN
$1.17B
$4.21M 0.14%
25,241
-7,118
-22% -$1.1M
CHRS icon
123
Coherus Oncology
CHRS
$198M
$4.13M 0.13%
282,740
+72,245
+34% +$1.23M
ZWS icon
124
Zurn Elkay Water Solutions
ZWS
$8.5B
$4.12M 0.13%
181,677
-60,046
-25% -$1.29M
MTRN icon
125
Materion
MTRN
$5.95B
$4.09M 0.13%
61,687
+12,830
+26% +$890K

Similar funds

Rice Hall James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Rice Hall James & Associates held 329 positions worth $3.07B, up 7.9% from $2.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q1 2021 filing shows 29 new, 101 increased, 173 reduced and 14 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 264,558 shares worth $18.1M. The largest sale was Etsy, an estimated $49.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q1 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 264,558 shares worth $18.1M.
  • Rice Hall James & Associates added most to Stride in Q1 2021, an estimated $15.5M increase.
  • Rice Hall James & Associates's biggest Q1 2021 reduction was Etsy, cutting an estimated $49.1M.
  • Rice Hall James & Associates fully exited Grand Canyon Education in Q1 2021, selling an estimated $6.68M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $3.07B portfolio in Q1 2021.
  • Rice Hall James & Associates opened 29 new positions and closed 14 in Q1 2021.
  • Rice Hall James & Associates's portfolio value rose 7.9% quarter-over-quarter to $3.07B.

Based on Rice Hall James & Associates's 13F filing for Q1 2021, filed 14 May 2021.